Age-related differences in patient-reported and objective measures of chemotherapy-induced peripheral neuropathy among cancer survivors

PURPOSE: While older adults with cancer are more likely to develop chemotherapy-induced peripheral neuropathy (CIPN), the study aimed to determine if patient-reported and objective measures of CIPN differ by age among cancer survivors. METHODS: Cancer survivors with persistent CIPN after completion of platinum and/or taxane chemotherapy completed CIPN questionnaires (severity, interference with activities, sensory and motor symptoms) and objective testing (light touch, vibration, pain, cold sensation). CIPN measures were compared by age group (